365 related articles for article (PubMed ID: 9848446)
21. Characterization of rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis isolated in China.
Huang H; Jin Q; Ma Y; Chen X; Zhuang Y
Tuberculosis (Edinb); 2002; 82(2-3):79-83. PubMed ID: 12356458
[TBL] [Abstract][Full Text] [Related]
22. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis.
Hirata T; Saito H; Tomioka H; Sato K; Jidoi J; Hosoe K; Hidaka T
Antimicrob Agents Chemother; 1995 Oct; 39(10):2295-303. PubMed ID: 8619585
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the rpoB gene of rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Lithuania.
Bakonyte D; Baranauskaite A; Cicenaite J; Sosnovskaja A; Stakenas P
Int J Tuberc Lung Dis; 2005 Aug; 9(8):936-8. PubMed ID: 16104644
[TBL] [Abstract][Full Text] [Related]
25. The in-vitro activities of novel benzoxazinorifamycins against Mycobacterium leprae.
Dhople AM; Ibanez MA
J Antimicrob Chemother; 1995 Apr; 35(4):463-71. PubMed ID: 7628981
[TBL] [Abstract][Full Text] [Related]
26. Use of a high-density DNA probe array for detecting mutations involved in rifampicin resistance in Mycobacterium tuberculosis.
Sougakoff W; Rodrigue M; Truffot-Pernot C; Renard M; Durin N; Szpytma M; Vachon R; Troesch A; Jarlier V
Clin Microbiol Infect; 2004 Apr; 10(4):289-94. PubMed ID: 15059116
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria.
Dickinson JM; Mitchison DA
Tubercle; 1987 Sep; 68(3):177-82. PubMed ID: 2834842
[TBL] [Abstract][Full Text] [Related]
28. Bacteriological and molecular analysis of rifampin-resistant Mycobacterium tuberculosis strains isolated in Australia.
Yuen LK; Leslie D; Coloe PJ
J Clin Microbiol; 1999 Dec; 37(12):3844-50. PubMed ID: 10565894
[TBL] [Abstract][Full Text] [Related]
29. Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosis.
Ohno H; Koga H; Kuroita T; Tomono K; Ogawa K; Yanagihara K; Yamamoto Y; Miyamoto J; Tashiro T; Kohno S
Am J Respir Crit Care Med; 1997 Jun; 155(6):2057-63. PubMed ID: 9196115
[TBL] [Abstract][Full Text] [Related]
30. [Detection and characteristics of rpoB gene mutations in rifampicin-resistant clinical strains of M. tuberculosis].
Generozov EV; Al'tshuler ML; Govorun VM; Lopukhin IuM; Golyshevskaia VI; Chernousova LN; Khomenko AG
Probl Tuberk; 1999; (2):39-42. PubMed ID: 10420750
[TBL] [Abstract][Full Text] [Related]
31. Comparison of rifabutin susceptibility and rpoB mutations in multi-drug-resistant Mycobacterium tuberculosis strains by DNA sequencing and the line probe assay.
Yoshida S; Suzuki K; Iwamoto T; Tsuyuguchi K; Tomita M; Okada M; Sakatani M
J Infect Chemother; 2010 Oct; 16(5):360-3. PubMed ID: 20354890
[TBL] [Abstract][Full Text] [Related]
32. Rifampin resistance in Mycobacterium kansasii is associated with rpoB mutations.
Klein JL; Brown TJ; French GL
Antimicrob Agents Chemother; 2001 Nov; 45(11):3056-8. PubMed ID: 11600355
[TBL] [Abstract][Full Text] [Related]
33. Characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from the Middle East.
Ahmad S; Araj GF; Akbar PK; Fares E; Chugh TD; Mustafa AS
Diagn Microbiol Infect Dis; 2000 Dec; 38(4):227-32. PubMed ID: 11146248
[TBL] [Abstract][Full Text] [Related]
34. Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis.
Zaw MT; Emran NA; Lin Z
J Infect Public Health; 2018; 11(5):605-610. PubMed ID: 29706316
[TBL] [Abstract][Full Text] [Related]
35. Incidence of cross resistance between rifampicin and rifabutin in Mycobacterium tuberculosis strains in Izmir, Turkey.
Senol G; Erbaycu A; Ozsöz A
J Chemother; 2005 Aug; 17(4):380-4. PubMed ID: 16167516
[TBL] [Abstract][Full Text] [Related]
36. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis isolates in Spain and their rapid detection by PCR-enzyme-linked immunosorbent assay.
Garcia L; Alonso-Sanz M; Rebollo MJ; Tercero JC; Chaves F
J Clin Microbiol; 2001 May; 39(5):1813-8. PubMed ID: 11325996
[TBL] [Abstract][Full Text] [Related]
37. Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCG.
Rastogi N; Goh KS; Berchel M; Bryskier A
J Antimicrob Chemother; 2000 Oct; 46(4):565-70. PubMed ID: 11020253
[TBL] [Abstract][Full Text] [Related]
38. Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge.
van Ingen J; Aarnoutse R; de Vries G; Boeree MJ; van Soolingen D
Int J Tuberc Lung Dis; 2011 Jul; 15(7):990-2. PubMed ID: 21682979
[TBL] [Abstract][Full Text] [Related]
39. [Characterization of the rpoB gene mutations in clinical isolates of rifampicin-resistant Mycobacterium tuberculosis].
González N; Torres MJ; Palomares JC; Aznar J
Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):404-7. PubMed ID: 9887626
[TBL] [Abstract][Full Text] [Related]
40. Geographical profile of rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis isolates in Sri Lanka.
Adikaram CP; Perera J; Wijesundera SS
Microb Drug Resist; 2012 Oct; 18(5):525-30. PubMed ID: 22731859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
